`

KaliVir Immunotherapeutics

Biotechnology Research

revenue-icon Revenue
11M - 100M
funding-icon Total Funding
--
size-icon Size
11 - 50

Frequently Asked Questions About KaliVir Immunotherapeutics

What does Kalivir immunotherapeutics do?+

KaliVir Immunotherapeutics was founded in 2019 to pioneer a unique and novel approach to cancer treatment that engages a virus natural ability to replicate in and kill cancer cells. This modality is known as oncolytic viral immunotherapy. KaliVirs cutting-edge, next generation oncolytic viral immunotherapy programs combine technologies developed in-house and licensed from University of Pittsburghs world-class oncolytic virus and immunotherapy research programs

What is Kalivir immunotherapeutics's industry? +

Kalivir immunotherapeutics operates in the Biotechnology research industry.

What is Kalivir immunotherapeutics's revenue? +

Kalivir immunotherapeutics's revenue is 11m - 100m

What is Kalivir immunotherapeutics's company size? +

Kalivir immunotherapeutics has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.